Browsing Tag
Vanflyta
1 post
Chipscreen Biosciences wins China IND approval for CS43158, putting AML resistance strategy to the test
China's approval of clinical testing for CS43158 opens a new development opportunity for Chipscreen Biosciences in acute myeloid leukemia, but its ambitious multikinase approach must now demonstrate meaningful benefits beyond existing FLT3-targeted treatments.